OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Mony deLeon

1 Projects | 1 Researchers | $85,000 Invested

1999

New York University

Mony deLeon, EdD

MRI and CSF tau Protein Levels: An Early Screening Test for Alzheimer's Disease

  • Funding Amount: $85,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed